Drugs / Supplemental oxygen
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial · 1 missed | ||||||
| Phase 3 | NCT00233324 | Feb 2005 → Feb 2009 | bronchopulmonary dysplasia, fetal growth restriction, retinopathy of prematurity | NICHD Neonatal Research Network | Completed | Missed primary |
| Comparator or background therapy1 trial | ||||||
| — | NCT01734954 Background | Apr → Aug 2013 | — | CES University | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Supplemental oxygen | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00233324 ↗ |